I kinda like FOLFOXIRIB.

June 5, 2017. This JAMA Onc article reports FOLFOXIRI-bevacizumab converts 40% of patients with unresectable metastatic colon cancer to resectable with 25% getting an R0 resection. So you heard it here first, FOLFOXIRIB. And did someone say SBRT?

Comments

Popular Posts